We present a continuous threshold model (CTM) of cascade dynamics for a network of agents with realvalued activity levels that change continuously in time. The model generalizes the linear threshold model (LTM) from the literature, where an agent becomes active (adopts an innovation) if the fraction of its neighbors that are active is above a threshold. With the CTM we study the influence on cascades of heterogeneity in thresholds for a network comprised of a chain of three clusters of agents, each distinguished by a different threshold. The system is most sensitive to change as the dynamics pass through a bifurcation point: if the bifurcation is supercritical the response will be contained, while if the bifurcation is subcritical the response will be a cascade. We show that there is a subcritical bifurcation, thus a cascade, in response to an innovation if there is a large enough disparity between the thresholds of sufficiently large clusters on either end of the chain; otherwise the response will be contained.
Emergency vehicles (EMVs) play a crucial role in responding to time-critical events such as medical emergencies and fire outbreaks in an urban area. The less time EMVs spend traveling through the traffic, the more likely it would help save people's lives and reduce property loss. To reduce the travel time of EMVs, prior work has used route optimization based on historical traffic-flow data and traffic signal pre-emption based on the optimal route. However, traffic signal pre-emption dynamically changes the traffic flow which, in turn, modifies the optimal route of an EMV. In addition, traffic signal pre-emption practices usually lead to significant disturbances in traffic flow and subsequently increase the travel time for non-EMVs. In this paper, we propose EMVLight, a decentralized reinforcement learning (RL) framework for simultaneous dynamic routing and traffic signal control. EMVLight extends Dijkstra's algorithm to efficiently update the optimal route for the EMVs in real-time as it travels through the traffic network. The decentralized RL agents learn network-level cooperative traffic signal phase strategies that not only reduce EMV travel time but also reduce the average travel time of non-EMVs in the network. This benefit has been demonstrated through comprehensive experiments with synthetic and real-world maps. These experiments show that EMVLight outperforms benchmark transportation engineering techniques and existing RL-based signal control methods.
Although various radiolabeled tryptophan analogs have been developed to monitor tryptophan metabolism using positron emission tomography (PET) for various human diseases including melanoma and other cancers, their application can be limited due to the complicated synthesis process. In this study, we demonstrated that photoredox radiofluorination represents a simple method to access novel tryptophan-based PET agents. In brief, 4-F-5-OMe-tryptophans (L/D-T13) and 6-F-5-OMe-tryptophans (L/D-T18) were easily synthesized. The 18 F-labeled analogs were produced by photoredox radiofluorination with radiochemical yields ranging from 2.6 ± 0.5% to 32.4 ± 4.1% (3 ≤ n ≤ 5, enantiomeric excess ≥ 99.0%) and over 98.0% radiochemical purity. Small animal imaging showed that L-[ 18 F]T13 achieved 9.58 ± 0.26%ID/g tumor uptake and good contrast in B16F10 tumor-bearing mice (n = 3). Clearly, L-[ 18 F]T13 exhibited prominent tumor uptake, warranting future evaluations of its potential usage in precise immunotherapy monitoring.
The linear threshold model (LTM) has been used to study spread on single-layer networks defined by one inter-agent sensing modality and agents homogeneous in protocol. We define and analyze the heterogeneous multiplex LTM to study spread on multi-layer networks with each layer representing a different sensing modality and agents heterogeneous in protocol. Protocols are designed to distinguish signals from different layers: an agent becomes active if a sufficient number of its neighbors in each of any a of the m layers is active. We focus on Protocol OR, when a = 1, and Protocol AND, when a = m, which model agents that are most and least readily activated, respectively. We develop theory and algorithms to compute the size of the spread at steady state for any set of initially active agents and to analyze the role of distinguished sensing modalities, network structure, and heterogeneity. We show how heterogeneity manages the tension in spreading dynamics between sensitivity to inputs and robustness to disturbances.
Emergency vehicles (EMVs) play a critical role in a city's response to time-critical events such as medical emergencies and fire outbreaks. The existing approaches to reduce EMV travel time employ route optimization and traffic signal pre-emption without accounting for the coupling between route these two subproblems. As a result, the planned route often becomes suboptimal. In addition, these approaches also do not focus on minimizing disruption to the overall traffic flow. To address these issues, we introduce EMVLight in this paper. This is a decentralized reinforcement learning (RL) framework for simultaneous dynamic routing and traffic signal control. EMVLight extends Dijkstra's algorithm to efficiently update the optimal route for an EMV in real-time as it travels through the traffic network. Consequently, the decentralized RL agents learn network-level cooperative traffic signal phase strategies that reduce EMV travel time and the average travel time of non-EMVs in the network. We have carried out comprehensive experiments with synthetic and real-world maps to demonstrate this benefit. Our results show that EMVLight outperforms benchmark transportation engineering techniques as well as existing RL-based traffic signal control methods.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.